Related Experiment Videos

Serum cholesterol levels are underevaluated and undertreated

P G Danias1, S O'Mahony, M J Radford

  • 1Cardiology Division, University of Connecticut Health Center, Farmington 06030-1305, USA.

The American Journal of Cardiology
|June 19, 1998
PubMed

Insights

Less than half of patients with high cholesterol met treatment guidelines but did not receive lipid-lowering agents within a year. This highlights a gap in managing hypercholesterolemia according to established protocols.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Hypercholesterolemia is a significant risk factor for cardiovascular disease.
  • Current guidelines provide clear criteria for initiating lipid-lowering therapy.
  • Effective management of high cholesterol is crucial for preventing adverse cardiovascular events.

Purpose of the Study:

  • To evaluate the adherence to Adult Treatment Panel II/National Education Cholesterol Program guidelines for hypercholesterolemia management.
  • To assess the rate of lipid-lowering agent initiation in patients meeting guideline criteria.

Main Methods:

  • Retrospective review of data from 147 patients.
  • Analysis of patient records from a Veterans Administration hospital.
  • Assessment of lipid levels and prescribed therapies over a 1-year follow-up period.

Main Results:

  • Less than 50% of patients meeting guideline criteria for medical therapy received lipid-lowering agents.
  • A significant proportion of patients with hypercholesterolemia were undertreated.
  • Adherence to treatment initiation protocols was suboptimal.

Conclusions:

  • There is a considerable gap between guideline recommendations and actual clinical practice in managing hypercholesterolemia.
  • Further interventions are needed to improve the initiation of lipid-lowering therapy in eligible patients.
  • Optimizing hypercholesterolemia management is essential for reducing cardiovascular risk.

Related Concept Videos